Last reviewed · How we verify

Biotene oral spray — Competitive Intelligence Brief

Biotene oral spray (Biotene oral spray) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Saliva substitute. Area: Otolaryngology / Oral Health.

marketed Saliva substitute Otolaryngology / Oral Health Small molecule Live · refreshed every 30 min

Target snapshot

Biotene oral spray (Biotene oral spray) — University of Southern California. Biotene oral spray provides lubrication and moisture to the oral cavity to relieve symptoms of dry mouth (xerostomia).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Biotene oral spray TARGET Biotene oral spray University of Southern California marketed Saliva substitute

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Saliva substitute class)

  1. University of Southern California · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Biotene oral spray — Competitive Intelligence Brief. https://druglandscape.com/ci/biotene-oral-spray. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: